In this video, Scarlett Gomez, MD, PhD, discusses the significance of the private public collaboration between the National Cancer Institute’s Surveillance Epidemiology, and End Results program and the Oncotype DX Genomic Prostate Score assay in investing patterns in prostate genomic testing.Gomez is a professor in the department of epidemiology and biostatistics at the University of California, San Francisco.
Destigmatizing Urology: Dr. Pruthi discusses mental health
May 23rd 2022“I think we often encourage our patients to share concerns about depression, anxiety, and other mental health conditions, yet are less likely ourselves to seek help due to this issue of stigma,” says Raj S. Pruthi, MD, MHA, FACS.
Genomic test shows prognostic value for prostate cancer progression
December 11th 2023"Our studies consistently demonstrated that data from the Decipher Prostate Genomic Classifier was more reliably predictive of prostate cancer progression and underlying pathology than any other clinical data available, including MRI," says Eric Kim, MD.